Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
Mesoblast Ltd
ASX:MSB
|
AU |
Intrinsic Value
The
intrinsic value for
Rigel Pharmaceuticals Inc (RIGL)
under the Base Case is
45.14
USD.
Compared with the current market price of 27.04 USD, the stock appears
Undervalued by 40%.
Both DCF and multiples point to undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Rigel Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Rigel Pharmaceuticals Inc
Earnings Waterfall
Rigel Pharmaceuticals Inc
The
intrinsic value for
Rigel Pharmaceuticals Inc (RIGL)
under the Base Case is
45.14
USD.
Compared with the current market price of 27.04 USD, the stock appears Undervalued by 40%.